Philip Morris International Stock Forecast
NYSE: PMHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PM analyst consensus
Consensus (16 analysts)
none
Avg. price target
$208.13+8.01%
- Strong buy 3
- Buy 9
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 16 Wall Street analysts covering Philip Morris International (2026-10-07), 12 rate the stock a buy or strong buy, 4 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $208.13, with a high estimate of $230.00 and a low estimate of $175.00. The average target implies upside of 8.0% from the current price of $192.69.
The spread between the highest and lowest targets is 31.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 19% |
| Buy | 9 | 56% |
| Hold | 4 | 25% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $175.00 | -9.18% |
| Average target | $208.13 | +8.01% |
| High target | $230.00 | +19.36% |